Published in Curr Cancer Drug Targets on March 01, 2012
Characterization of the blood-brain barrier of metastatic and primary malignant neoplasms. J Neurosurg (2013) 1.86
Application of dental nanomaterials: potential toxicity to the central nervous system. Int J Nanomedicine (2015) 1.16
Sustained-release nanoART formulation for the treatment of neuroAIDS. Int J Nanomedicine (2015) 1.07
Directed evolution of bacteriorhodopsin for applications in bioelectronics. J R Soc Interface (2013) 0.89
Modulation of the Wnt/beta-catenin pathway in human oligodendroglioma cells by Sox17 regulates proliferation and differentiation. Cancer Lett (2013) 0.85
Polyethylene glycol-polylactic acid nanoparticles modified with cysteine-arginine-glutamic acid-lysine-alanine fibrin-homing peptide for glioblastoma therapy by enhanced retention effect. Int J Nanomedicine (2014) 0.78
Development of a preclinical therapeutic model of human brain metastasis with chemoradiotherapy. Int J Mol Sci (2013) 0.76
Magnetic micelles for DNA delivery to rat brains after mild traumatic brain injury. Nanomedicine (2014) 0.75
The use of nanoparticulates to treat breast cancer. Nanomedicine (Lond) (2017) 0.75
KRAS codon 61, 146 and BRAF mutations predict resistance to cetuximab plus irinotecan in KRAS codon 12 and 13 wild-type metastatic colorectal cancer. Br J Cancer (2009) 3.73
Alendronate for the treatment of osteoporosis in men. N Engl J Med (2000) 3.11
De novo design and structural characterization of proteins and metalloproteins. Annu Rev Biochem (1999) 2.69
Management of cancer pain: ESMO Clinical Practice Guidelines. Ann Oncol (2012) 2.07
Concordance between telepathologic diagnosis and conventional histopathologic diagnosis: a multiobserver store-and-forward study on 20 skin specimens. Arch Dermatol (2002) 2.07
Potential utility of early metabolic response by 18F-2-fluoro-2-deoxy-D-glucose-positron emission tomography/computed tomography in a selected group of breast cancer patients receiving preoperative chemotherapy. Eur J Cancer (2013) 2.01
Antigen retrieval techniques in immunohistochemistry: comparison of different methods. J Pathol (1997) 2.01
17beta-Estradiol induces cyclin D1 gene transcription, p36D1-p34cdk4 complex activation and p105Rb phosphorylation during mitogenic stimulation of G(1)-arrested human breast cancer cells. Oncogene (1996) 2.01
Biochemical and radiologic improvement in Paget's disease of bone treated with alendronate: a randomized, placebo-controlled trial. Am J Med (1996) 2.00
Familial papillary thyroid microcarcinoma: a new clinical entity. Lancet (1999) 1.98
De novo design of helical bundles as models for understanding protein folding and function. Acc Chem Res (2000) 1.84
The basal-like breast carcinoma phenotype is regulated by SLUG gene expression. J Pathol (2008) 1.83
Natural history of bone metastasis in colorectal cancer: final results of a large Italian bone metastases study. Ann Oncol (2012) 1.78
Interobserver variability on the histopathologic diagnosis of cutaneous melanoma and other pigmented skin lesions. J Clin Oncol (1996) 1.67
Idiosyncratic reaction after oxaliplatin infusion. Ann Oncol (2001) 1.63
Genetic modulation of the Let-7 microRNA binding to KRAS 3'-untranslated region and survival of metastatic colorectal cancer patients treated with salvage cetuximab-irinotecan. Pharmacogenomics J (2010) 1.63
Alendronate and estrogen effects in postmenopausal women with low bone mineral density. Alendronate/Estrogen Study Group. J Clin Endocrinol Metab (2000) 1.58
Bone metastases in breast cancer: higher prevalence of osteosclerotic lesions. Radiol Med (2007) 1.58
Pelvic ultrasonography in normal girls and in girls with pubertal precocity. Acta Paediatr (1998) 1.56
Granular cell ameloblastoma: a case report with histochemical findings. Eur J Cancer B Oral Oncol (1996) 1.49
From chronic overnutrition to insulin resistance: the role of fat-storing capacity and inflammation. Nutr Metab Cardiovasc Dis (2009) 1.49
Brain uncoupling protein 2: uncoupled neuronal mitochondria predict thermal synapses in homeostatic centers. J Neurosci (1999) 1.48
Outcome of antenatally diagnosed intracranial hemorrhage: case series and review of the literature. Ultrasound Obstet Gynecol (2003) 1.48
Deoxyhypusine hydroxylase from rat testis. Partial purification and characterization. J Biol Chem (1986) 1.44
The translation elongation factor 1A in tumorigenesis, signal transduction and apoptosis: review article. Amino Acids (2004) 1.44
Onychoblastoma (hamartoma of the nail unit): a new entity? Br J Dermatol (2005) 1.43
Gastrointestinal autonomic nerve tumor of the jejunum. Case report and review of the literature. Ital J Gastroenterol Hepatol (1997) 1.42
Silencing the MET oncogene leads to regression of experimental tumors and metastases. Oncogene (2007) 1.42
Endocrine pancreatic tumors: factors correlated with survival. Ann Oncol (2005) 1.41
Leiomyomatosis in pelvic lymph nodes. Histopathology (1992) 1.39
Morphometric analysis of AgNORs in uveal malignant melanoma. Anal Quant Cytol Histol (1998) 1.39
Reciprocal bone marrow transplantation between brother and sister. Bone Marrow Transplant (2002) 1.39
Suppression of autoantibodies to factor VIII and correction of factor VIII deficiency with a combined steroid-cyclophosphamide-porcine factor VIII treatment in a patient with rheumatoid arthritis. J Intern Med (1992) 1.38
A primary, lateral-cervical medullary thyroid carcinoma: a case report. J Clin Endocrinol Metab (1996) 1.38
Inhibition of in vitro growth of enteropathogens by new Lactobacillus isolates of human intestinal origin. FEMS Microbiol Lett (1997) 1.34
High prevalence of retinoblastoma protein loss in triple-negative breast cancers and its association with a good prognosis in patients treated with adjuvant chemotherapy. Ann Oncol (2009) 1.34
Transcatheter closure of persistent ductus arteriosus with the Amplatzer duct occluder in very young symptomatic children. Heart (2004) 1.31
Odanacatib for the treatment of postmenopausal osteoporosis: development history and design and participant characteristics of LOFT, the Long-Term Odanacatib Fracture Trial. Osteoporos Int (2014) 1.29
Cetuximab rechallenge in metastatic colorectal cancer patients: how to come away from acquired resistance? Ann Oncol (2012) 1.28
Clinically equivocal melanocytic skin lesions with features of regression: a dermoscopic-pathological study. Br J Dermatol (2004) 1.27
The role of eukaryotic initiation factor 5A in the control of cell proliferation and apoptosis. Amino Acids (2001) 1.26
Alendronate for the treatment of pediatric osteogenesis imperfecta: a randomized placebo-controlled study. J Clin Endocrinol Metab (2010) 1.22
Zoledronic acid induces antiproliferative and apoptotic effects in human pancreatic cancer cells in vitro. Br J Cancer (2003) 1.21
Pharmacogenetic profiling in patients with advanced colorectal cancer treated with first-line FOLFIRI chemotherapy. Pharmacogenomics J (2007) 1.20
Diagnosis of benign and malignant portal vein thrombosis in cirrhotic patients with hepatocellular carcinoma: color Doppler US, contrast-enhanced US, and fine-needle biopsy. Abdom Imaging (2007) 1.20
Dyskerin expression influences the level of ribosomal RNA pseudo-uridylation and telomerase RNA component in human breast cancer. J Pathol (2006) 1.20
Gemcitabine/cannabinoid combination triggers autophagy in pancreatic cancer cells through a ROS-mediated mechanism. Cell Death Dis (2011) 1.18
Elocalcitol inhibits inflammatory responses in human thyroid cells and T cells. Endocrinology (2008) 1.18
The role of Aurora-A inhibitors in cancer therapy. Ann Oncol (2007) 1.16
Toward the de novo design of a catalytically active helix bundle: a substrate-accessible carboxylate-bridged dinuclear metal center. J Am Chem Soc (2001) 1.15
Uncoupling proteins-2 and 3 influence obesity and inflammation in transgenic mice. Int J Obes Relat Metab Disord (2003) 1.15
Comparative study of alendronate versus etidronate for the treatment of Paget's disease of bone. J Clin Endocrinol Metab (1996) 1.15
Oxidative stress and ERK1/2 phosphorylation as predictors of outcome in hepatocellular carcinoma patients treated with sorafenib plus octreotide LAR. Cell Death Dis (2011) 1.14
Cetuximab and irinotecan as third-line therapy in advanced colorectal cancer patients: a single centre phase II trial. Br J Cancer (2006) 1.14
Diagnostic and prognostic implications of the World Health Organization classification of neuroendocrine tumors. J Endocrinol Invest (2008) 1.14
Accelerated bone mass senescence after hematopoietic stem cell transplantation. Transl Med UniSa (2013) 1.13
Interferon-alpha induces apoptosis in human KB cells through a stress-dependent mitogen activated protein kinase pathway that is antagonized by epidermal growth factor. Cell Death Differ (1999) 1.13
Dieulafoy's disease associated with early gastric cancer. J Clin Pathol (1995) 1.13
Survivin, a potential early predictor of tumor progression in the oral mucosa. J Dent Res (2003) 1.13
Review of probiotics available to modify gastrointestinal flora. Int J Antimicrob Agents (1999) 1.12
Thromboxane A(2) regulation of endothelial cell migration, angiogenesis, and tumor metastasis. Biochem Biophys Res Commun (2000) 1.12
Percutaneous aspiration biopsy of the pancreas under ultrasonic guidance. N Engl J Med (1975) 1.12
Diagnosis of midline anomalies of the fetal brain with the three-dimensional median view. Ultrasound Obstet Gynecol (2006) 1.11
Clone heterogeneity in diploid and aneuploid breast carcinomas as detected by FISH. Cytometry (2001) 1.11
Inflamed eye in Marfan's syndrome with posteriorly luxated lens. Ophthalmologica (1986) 1.11
Cardiac resynchronisation therapy response predicts occurrence of atrial fibrillation in non-ischaemic dilated cardiomyopathy. Int J Clin Pract (2011) 1.10
Emerging strategies to strengthen the anti-tumour activity of type I interferons: overcoming survival pathways. Curr Cancer Drug Targets (2009) 1.10
eIF5A isoforms and cancer: two brothers for two functions? Amino Acids (2011) 1.09
The eukaryotic initiation factor 5A is involved in the regulation of proliferation and apoptosis induced by interferon-alpha and EGF in human cancer cells. J Biochem (2003) 1.09
WNT pathway in oral cancer: epigenetic inactivation of WNT-inhibitors. Oncol Rep (2010) 1.09
Expression of cell cycle and apoptosis-related proteins in sporadic odontogenic keratocysts and odontogenic keratocysts associated with the nevoid basal cell carcinoma syndrome. J Dent Res (1999) 1.08
Change of Th0 to Th1 cell-cytokine profile following tuberculosis chemotherapy. Scand J Immunol (2000) 1.08
Compliance and administration methods in management of type 1 diabetes. Acta Biomed (2005) 1.07
An anomalous positron abundance in cosmic rays with energies 1.5-100 GeV. Nature (2009) 1.07
Odontogenic myxoma: report of a case with peculiar features. J Oral Maxillofac Surg (1991) 1.06
Tricholemmal carcinoma: a study of seven cases. J Cutan Pathol (1992) 1.06
Survivin expression in oral squamous cell carcinoma. Br J Cancer (2003) 1.06
Tertiary templates for the design of diiron proteins. Curr Opin Struct Biol (1999) 1.06
Familial clustering of Langerhans cell histiocytosis. Br J Haematol (1999) 1.06
Aggressive forms of gastric neuroendocrine tumors in multiple endocrine neoplasia type I. Am J Surg Pathol (1997) 1.06
Villin, intestinal brush border hydrolases and keratin polypeptides in intestinal metaplasia and gastric cancer; an immunohistologic study emphasizing the different degrees of intestinal and gastric differentiation in signet ring cell carcinomas. Virchows Arch A Pathol Anat Histopathol (1988) 1.05
Apoptosis: a relevant tool for anticancer therapy. Ann Oncol (2006) 1.05
Nuclear receptors agonists exert opposing effects on the inflammation dependent survival of breast cancer stem cells. Cell Death Differ (2012) 1.05
Diagnostic accuracy of the serum profile of gastric mucosa in relation to histological and morphometric diagnosis of atrophy. Aliment Pharmacol Ther (2005) 1.05
Nuclear and cytoplasmic expression of survivin in 67 surgically resected pancreatic cancer patients. Br J Cancer (2005) 1.05
Adjuvant colon cancer chemotherapy: where we are and where we'll go. Cancer Treat Rev (2010) 1.05
BRAF and PIK3CA genes are somatically mutated in hepatocellular carcinoma among patients from South Italy. Cell Death Dis (2012) 1.05
Is serum troponin T a useful marker of myocardial damage in newborn infants with perinatal asphyxia? Acta Paediatr (2007) 1.05
Cardiac adverse effects of early dexamethasone treatment in preterm infants: a randomized clinical trial. J Clin Pharmacol (2001) 1.05
Percutaneous ethanol injection efficacy in the treatment of large symptomatic thyroid cystic nodules: ten-year follow-up of a large series. Thyroid (2002) 1.04